Augustine Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.37M | Buy |
4,508
+39
| +0.9% | +$20.5K | 0.63% | 27 |
|
|
2025
Q1 | $2.83M | Sell |
4,469
-5
| -0.1% | -$3.17K | 0.83% | 25 |
|
|
2024
Q4 | $3.19M | Sell |
4,474
-68
| -1% | -$48.4K | 0.84% | 22 |
|
|
2024
Q3 | $4.77M | Sell |
4,542
-14
| -0.3% | -$14.7K | 1.67% | 15 |
|
|
2024
Q2 | $4.79M | Buy |
4,556
+21
| +0.5% | +$22.1K | 1.85% | 13 |
|
|
2024
Q1 | $4.36M | Sell |
4,535
-11
| -0.2% | -$10.6K | 1.82% | 13 |
|
|
2023
Q4 | $3.99M | Buy |
4,546
+214
| +5% | +$188K | 1.77% | 17 |
|
|
2023
Q3 | $3.57M | Sell |
4,332
-136
| -3% | -$112K | 1.65% | 14 |
|
|
2023
Q2 | $3.21M | Sell |
4,468
-10
| -0.2% | -$7.19K | 1.48% | 17 |
|
|
2023
Q1 | $3.68M | Sell |
4,478
-26
| -0.6% | -$21.4K | 1.82% | 15 |
|
|
2022
Q4 | $3.25M | Sell |
4,504
-93
| -2% | -$67.1K | 1.8% | 17 |
|
|
2022
Q3 | $3.17M | Buy |
4,597
+4
| +0.1% | +$2.76K | 2.08% | 15 |
|
|
2022
Q2 | $2.72M | Sell |
4,593
-372
| -7% | -$220K | 1.67% | 20 |
|
|
2022
Q1 | $3.47M | Sell |
4,965
-11
| -0.2% | -$7.68K | 1.74% | 18 |
|
|
2021
Q4 | $3.14M | Buy |
4,976
+41
| +0.8% | +$25.9K | 1.54% | 22 |
|
|
2021
Q3 | $2.99M | Sell |
4,935
-107
| -2% | -$64.8K | 1.59% | 22 |
|
|
2021
Q2 | $2.82M | Sell |
5,042
-211
| -4% | -$118K | 1.45% | 23 |
|
|
2021
Q1 | $2.49M | Buy |
5,253
+39
| +0.7% | +$18.4K | 1.31% | 26 |
|
|
2020
Q4 | $2.52M | Sell |
5,214
-14
| -0.3% | -$6.76K | 1.31% | 27 |
|
|
2020
Q3 | $2.93M | Sell |
5,228
-356
| -6% | -$199K | 1.72% | 20 |
|
|
2020
Q2 | $3.48M | Buy |
5,584
+2,218
| +66% | +$1.38M | 2.1% | 16 |
|
|
2020
Q1 | $1.64M | Buy |
+3,366
| New | +$1.64M | 1.17% | 26 |
|